Is there any update on the company's licensing pipeline or expansion plans that could impact future growth?

Based on the information provided in the GlobeNewswire release — “MariMed Reports Second Quarter 2025 Earnings” – the press release focuses primarily on the company’s financial performance for the quarter ended June 30, 2025. The summary you have shared does not mention any of the following:

• New or pending cannabis licenses (e.g., applications in progress, pending approvals, or recent award of new licenses)
• Specific expansion projects (such as new cultivation sites, retail store openings, geographic expansion beyond the current states of operation, or strategic partnerships aimed at growth)
• Milestones in the company’s licensing pipeline that could influence future revenue or market share

In other words, the excerpt you provided does not contain any updates regarding MariMed’s licensing pipeline or expansion plans that could affect future growth.

What This Means for Your Question

• No direct update: The news release does not give any new information about licensing or expansion activities.
• Potential indirect clues: Earnings releases sometimes include a “Management Discussion & Analysis” section that may discuss upcoming projects or licensing efforts. However, that portion was not included in the excerpt you provided.
• Next steps for confirmation:
  1. Review the full earnings release (often available as a PDF on the company’s investor‑relations site) – there may be a “Business Outlook” or “Strategic Initiatives” section that discusses licensing or expansion.
  2. Check recent press releases or the “Investor Relations” news feed for any separate announcements about new license applications or new store openings.
  3. Listen to the earnings call transcript (if available) – management typically addresses future growth initiatives during the Q&A portion.

Bottom Line

From the text you shared, there is no specific update on MariMed’s licensing pipeline or expansion plans that would impact future growth. To obtain that information you would need to consult the full earnings release, the company’s latest investor‑relations communications, or an upcoming earnings call transcript.